Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

17 June 2021: Clinical Research

Mid- and Long-Term Efficacy of Surgical Treatment of L1–2 Vertebral Tuberculosis with Subdiaphragmatic Extraperitoneal Approach

Fubiao Zhou 1BEF , Qian Wang 2CE , Liehua Liu 1BC , Shuanqiang Han 1B , Weidong Jin 1DF , Zili Wang 1ADFG*

DOI: 10.12659/MSM.932284

Med Sci Monit 2021; 27:e932284

Table 1 General information of the 2 groups before surgery.

Group AGroup BP value
Number of cases (cases)3532
Male/Female (cases)21/1419/130.958
Clinical symptoms
 Low back pain30281.000
 Nerve damage16150.924
 Low fever, night sweats17140.693
 Cold abscess21200.834
Cobb angle (°)21.60±4.2221.41±4.090.850
ESR (mm/h)63.03±14.6664.47±15.890.701
CRP (mg/L)41.19±25.4840.56±21.670.914
VAS score5.49±1.935.63±1.860.765
Group A: subdiaphragmatic extraperitoneal approach; Group B: thoracoabdominal approach. Values are presented as number or mean±standard deviation. ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; VAS – visual analog scale.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750